A commentary on 'The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs'
- PMID: 38768040
- PMCID: PMC11325988
- DOI: 10.1097/JS9.0000000000001548
A commentary on 'The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs'
Conflict of interest statement
The authors declare no conflicts of interes.
References
-
- Zhang Y, Sun Y, Hu X, et al. The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs. Int J Surg 2024;3. [Epub ahead of print]. doi: 10.1097/JS9.0000000000001381 - DOI - PMC - PubMed
-
- ADLARITY (donepezil transdermal system), Prescribing information, 2022. Accessed 3 April 2023.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
